Abstract: In one aspect, the present invention provides for a compound of Formula I in which in Formula I, the variables X1, X2a, X2b, X2c, R1, B, L, E, A and the subscript n are as defined herein. In another aspect, the present invention provides for pharmaceutical compositions comprising compounds of Formula I as well as methods for using compounds of Formula I for the treatment of diseases and conditions (e.g., cancer, thrombocythemia, etc) characterized by the expression or over-expression of Bcl-2 anti-apoptotic proteins, e.g., of anti-apoptotic Bcl-xL proteins.

Abstract: Disclosed herein are compounds that may be modulators of 5-HT receptors, and methods of making and using same.

Abstract: The present invention relates to an isolated bioactive molecule Caerulomycin A, derivatives and analogs thereof as effective immunosuppressive agents. The immunosuppressive property of the compound is targeted in particular against the lymphocytes, CD4+ T cells, CD8+ T cells and B cells and in the production of IL-4 and IFN-? and antibodies. The compound operates through a mechanism by downregulating the expression of activation marker CD28 and upregulating the immunosuppressive marker CTLA-4. Caerulomycin A has previously been isolated from Streptomyces caeruleus and found to have useful antifungal activity. Prior to the present invention however, this compound had not been determined to have immunomodulatory activity.

Abstract: Composition and methods of treating pain and reducing or reversing tolerance to opiate analgesics are disclosed. The composition and method utilize an opiate analgesic and an endothelin antagonist as active agents to treat pain in mammals, including humans.

Abstract: A pesticidal composition containing 4-methoxymethyl-2,3,5,6-tetrafluorobenzyl 3-(2-cyano-1-propenyl)-2,2-dimethylcyclopropanecarboxylate and 1-(2-chloro-1,3-thiazolyl)methyl-3-methyl-2-nitroguanidine has a high pesticidal activity.

Abstract: Embodiments of the present invention are directed to compositions and methods for the treatment of purpura. Preferred compositions comprise an ? adrenergic receptor agonist selected from selective ?1 adrenergic receptor agonist, selective ?2 adrenergic receptor agonist, non-selective ?1/?2 adrenergic receptor agonist, agents with ?2 adrenergic receptor agonist activity and combinations thereof, in a pharmaceutically acceptable carrier in order to treat and improve the cosmetic appearance of hemorrhagic (purpuric) lesions in the skin.

Abstract: Compounds corresponding to the formula (I) as defined in the disclosure, as well as methods for making such compounds, intermediates employed in such methods, pharmaceutical compositions containing the compounds of the invention, and methods of treatment using them.

Abstract: The invention encompasses novel amorphous and crystalline forms of carvedilol phosphate, carvedilol hydrogen phosphate, and carvedilol dihydrogen phosphate as well as methods of making the novel amorphous and crystalline forms. Also disclosed are pharmaceutical compositions comprising the novel amorphous and crystalline forms and uses thereof.

Abstract: The present invention relates to crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-yl-methyl)piperidin-4-yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride salt, a pharmaceutical formulation containing said salt and to methods for treating cancer and for inhibiting tumor growth using said salt.

Abstract: Disclosed is a 2-aminobutanol compound represented by the following formula (I) or a pharmaceutically acceptable acid addition salt thereof, or a hydrate thereof, or a solvate thereof, as well as a production method of the 2-aminobutanol compound of formula (I). The 2-aminobutanol compounds of formula (I) have few side effects including bradycardia and have superior peripheral blood lymphocyte-decreasing effects.

Abstract: A method of treating a patient in need of therapy for a cytokine dysregulation comprising administering to that patient a therapeutically effective dose of a compound of general formula: (I) wherein R1 and R2 together form a group —(CH2)n—CR4R5—(CH2)m— wherein n and m are independently selected integers 0, 1 or 2 and R4 and R5 are independently selected from H, C1-18 alkyl, C1-18alkoxy, C1-18n hydroxyalkyl, C2-18 alkenyl and C6-18aryl or aralykyl and R3 is the a fatty acyl group of an essential polyunsaturated fatty acid.

Abstract: Provided herein are compounds or fluorogenic probes which can be used as reagents for measuring, detecting and/or screening ROS or RNS such as peroxynitrite or hypochlorite. Provided also herein are methods that can be used to measure, directly or indirectly, the amount of peroxynitrite or hypochlorite in chemical samples and biological samples such as cells and tissues in living organisms. Specifically, the methods include the steps of contacting the fluorogenic probes disclosed herein with the samples to form one or more fluorescent compounds, and measuring fluorescence properties of the fluorescent compounds. Provided also herein are high-throughput screening fluorescent methods for detecting or screening peroxynitrite or compounds that can increase or decrease the level of peroxynitrite or hypochlorite in chemical and biological samples.

Abstract: The present invention provides an essentially pure compacted 2,2-Dibromo-3-nitrilopropionamide (DBNPA) in a granular and/or tablet and/or briquette and/or pellet form. The present invention further provides a process for preparing the same essentially pure compacted DBNPA.

Abstract: A method of treating or inhibiting depression in a patient with cardiovascular disease, especially a patient suffering from coronary artery or vascular disease, the method including administering, preferably orally, to the patient a therapeutically effective amount of an essential fatty acid composition comprising preferably more than 25% by weight of eicosapentanoic acid ethyl ester (EPA), of docosahexaenoic acid ethyl ester (DHA), or of a mixture of eicosapentanoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester (DHA), especially a mixture of EPA and DHA in an EPA/DHA ratio in the range from about 0.9 to about 1.5 at a dosage of from about 0.7 g to about 6 g per day.

Abstract: The present invention provides novel methods for treating a pulmonary disease state in mammals by up or down regulating indigenous in vivo levels of an inflammatory agent in mammalian cells comprising contacting the mammalian cells with a therapeutically effective amount of an inflammatory regulator, wherein the inflammatory agent is selected from the group consisting of cytokines, transforming growth factor-?, elastase, and white blood cells, and wherein the inflammatory regulator is selected from the group consisting of pyruvates and pyruvate precursors.

Abstract: A process is provided for producing peroxycarboxylic acids from carboxylic acid esters. More specifically, carboxylic acid esters are reacted with an inorganic peroxide, such as hydrogen peroxide, in the presence of an enzyme catalyst having perhydrolysis activity. The present perhydrolase catalysts are classified as members of the carbohydrate esterase family 7 (CE-7) based on the conserved structural features. Further, disinfectant formulations comprising the peracids produced by the processes described herein are provided.

Abstract: Disclosed herein are methods of using prodrugs of gamma aminobutyric acid (GABA) analogs and pharmaceutical compositions thereof to treat or prevent restless legs syndrome in humans, and pharmaceutical compositions of prodrugs of GABA analogs useful in treating or preventing restless legs syndrome.

Abstract: A composition is provided which comprises an acidic component, generally fulvic acid, having a molecular weight not exceeding 20,000 Daltons and a low content of the elements aluminum, mercury, cadmium, chromium and lead. The acidic component is preferably carbohydrate derived and preferably using a wet oxidation process.

Abstract: Provided is a composition for treating obesity which comprises an effective amount of a prostaglandin compound, especially, a compound of formula (I).

Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.

Abstract: The invention is for the combination and related methods of N-acetyl-cysteine oral, inhaled, or intravenous, or glutathione inhaled or intravenous, generally in combination with antibiotic and/or antiviral therapy to ameliorate the toxic effects of infection with materials used in Bioterror incidents such as Bacillus anthracis and smallpox virus, and alternatively, upon exposure to radiation, during testing, and vaccination, as treatment prior to treatment with antibiotic or antiviral therapy to ameliorate the toxic effects of infection and exposure with these organisms.

Abstract: Vasoconstrictors are administered topically to provide protection against the adverse effects, e.g., alopecia, mucositis or dermatitis, induced by chemotherapy or radiotherapy. Appropriate dosages and formulations of topical vasoconstrictors are provided. Methods for the use of such compositions are also provided.

Abstract: A method and system for collecting a plurality of slurries containing solid particles of varying particle size distribution and amount and performing a classification and separation on the slurries is provided whereby a fines-rich stream and a stream containing substantially coarse particles is obtained. The method and system includes separating the fines from the slurry liquid and thickening the separated coarse particles in a settling zone for subsequent use.

Abstract: A process and system for producing hydrocarbon compounds or fuels that recycle products of hydrocarbon compound combustion—carbon dioxide or carbon monoxide, or both, and water. The energy for recycling is electricity derived from preferably not fossil based fuels, like from nuclear fuels or from renewable energy. The process comprises electrolysing water, and then using hydrogen to reduce externally supplied carbon dioxide to carbon monoxide, then using so produced carbon monoxide together with any externally supplied carbon monoxide and hydrogen in Fischer-Tropsch reactors, with upstream upgrading to desired specification fuels—for example, gasoline, jet fuel, kerosene, diesel fuel, and others. Energy released in some of these processes is used by other processes. Using adiabatic temperature changes and isothermal pressure changes for gas processing and separation, large amounts of required energy are internally recycled using electric and heat distribution lines.

Abstract: A process is disclosed for the production of ethanol whereby synthesis gas is reacted to produce ethanol and carbon dioxide in the presence of a compound catalyst at a temperature in the range of 250° C. to 350° C. and a pressure of 1 atm. to 20 atm.

Abstract: A method is described for producing an osmotically compacted polyelectrolyte complex having a first region and a second region, the first region having a greater modulus than the second region. The method comprises contacting an article comprising polyelectrolyte complex to a solution comprising a preferred osmolyte of concentration sufficient to compact said polyelectrolyte complex and terminating the compaction process before the entire article is osmotically compacted. A method is also described for producing a article comprising water and an intermolecular blend of at least one positively charged polyelectrolyte polymer and at least one negatively charged polymer, said article having a core region and a surface region, the surface region having at least twice the elastic modulus of the core region, the method comprising contacting a starting article comprising a blend of said polymers with a solution of osmolyte, wherein the osmolyte is excluded from said article.

Abstract: Compositions foamable by exposure to microwave energy contain: (A) at least one compound bearing crosslinkable organic radicals for crosslinking, (B) at least one blowing agent which releases gas on heating, (C) at least one metal powder or metal compound, for example a metal oxide, individually, or a mixture thereof, which has microwave activity. Foams of uniform cell structure can be formulated with wide processing latitude.

Abstract: The UV-curable aqueous coating composition is characterized by using a UV-curable aqueous emulsion obtained by urethane reaction with a mixture including a poly-carbonate polyol or polyester polyol; an isocyanate compound; a urethane-reactive carboxylic acid; a UV-curable acrylic oligomer having 2 to 9 functional acrylate groups; a UV-curable acrylic monomer; and a urethane-reactive acrylate without an organic solvent. The aqueous composition provides good environmental acceptability and satisfactory film properties comparable to those of the prior oily UV-curable coating composition and, therefore, it is useful for coating various plastics.

Abstract: A macromolecule includes a polymer directly tethered or bonded to a polyatomic functionality. The polyatomic functionality can be located at a terminus of the polymer and can be generated concurrent with or soon after formation of the polymer. The macro-molecule can be prepared from a functionalized polymer by hydrolyzing and condensing (e.g., by a sol-gel process) functionalities in which one or more alkoxy groups are bound to a silica atom in the presence of an excess of a compound that includes a Si, Ti, Zr, Sn, Al, or Fe atom. Such macromolecules can be used in the manufacture of vulcanizates and tire components, either alone or blended with other polymers and/or other particulate fillers.

Abstract: An ink comprises metal thin film fragments having an average thickness of 0.01 to 0.1 ?m and an average particle diameter of 5 to 25 ?m, and a binder resin having at least one selected from the group consisting of a carboxyl group, a phosphoric acid group, a sulfonic acid group, metal salts thereof and an amino group. A laminated sheet comprises multilaminated at least two synthetic resin films for molding, and a decorative layer having mirror-like metallic luster formed at any laminate interface of the synthetic resin films, the decorative layer being an ink film made of the ink, the ink film having a thickness of 0.05 to 2.0 ?m.

Abstract: A smear resistant inkjet ink formulation includes ink includes between 0.1 and 6% colorant, between 1 and 40% solvent, between 0.3 and 10% latex binder having a particle size between 100 and 300 nm and a glass transition temperature between ?20 and +100 degrees Celsius, water, and between 0.1 and 4% hydrophobic styrene-acrylic or acrylic resin having an acid number between 50 and 250 and a molecular weight between 1,000 and 60,000 or a polyurethane resin having an acid number between 40 and 200 and a molecular weight between 3,000 and 400,000.

Abstract: The disclosure provides a highly loaded pearlescent pigment acrylic polymer slurry concentrate for use as a pearlescent pigment additive for an acrylic polymer sheet, comprising: (a) about 35 to about 45 wt. % of a pearlescent pigment based on the weight of the slurry concentrate; (b) about 1.0 to about 5.0 wt. % of a copolymer dispersant comprising a pigment functional component derived from a monomer selected from the group consisting of urethane or urea, epoxy-containing methacrylate esterified with aromatic carboxylic acids, aliphatic carboxylic acids, ammonia and primary, secondary and tertiary aliphatic amines, primary aromatic amines, and alkyl methacrylate; and a solvent functional component derived from a monomer selected from the group consisting of methyl methacrylate, butyl methacrylate, ethyl hexyl methacrylate, lauryl methacrylate, 1,2-propane diol, 6, hydroxyhexanoic acid, and 2-phenoxyethanol; (c) about 15 to about 45 wt. % of a (C1-C22) alkyl ((C1-C10)alk) acrylate; and (d) about 0.

Abstract: A method for preparing a filler composition useful for preparing a nanocomposite polymer is provided. The method includes a first step of dispersing a water dispersible filler material in a liquid comprising water to form a dispersion and a second step of replacing at least a portion of the water of the liquid with an organic solvent. The resulting filler composition features a water concentration of the liquid of less than six percent by weight, and the average size of at least one dimension of the filler material is less than two hundred nanometers upon examination by transmission electron microscopy of a representative freeze dried sample of the dispersion of the first step. A nanocomposite polymer, particularly and epoxy resin composition, can be prepared by mixing the above-made filler composition with one or more polymer, polymer component, monomer or prepolymer.

Abstract: The invention relates to a method for the production of a bituminous binder and a bituminous binder which can be obtained according to said method. The method for the preparation of the bituminous binder comprises a mixing stage of 0.05 5 wt. % acid, 0.5 25 wt. % rubber crumbs and 70 99.5 wt. % bitumen. The invention also relates to bituminous concretes comprising said binder and a method for the production and use thereof.

Abstract: The invention relates to asphalt emulsions comprising an asphalt component selected from the group consisting of a solvent extracted asphalt, an oxidized asphalt, and combinations thereof. The invention also relates to products made therefrom, including fibrous mats comprising a fiber component, such as glass fibers, and a binder component comprising an asphalt emulsion. The invention further relates to wet-laid processes for manufacturing fibrous mats and that employ the use of an amphoteric surfactant, which is applied to a wet fiber web prepared from a dispersion of fiber components, such as glass fibers.

Abstract: Disclosed is a transparent/translucent molding composition and process for making prepared from an impact modifier and a resin blend of polycarbonate and a cycloaliphatic polyester having a matching index of refraction.

Abstract: A composition comprising a clear thermoplastic blend comprising: (a) a polycarbonate component; and (b) a polyester component comprising (i) a polyester based substantially on 1,4 cyclohexane dimethanol and terephthalic acid monomer units, (ii) copolymers polyester based substantially on 1,4 cyclohexane dimethanol and terephthalic acid monomer units and modified with up to 25 mol % of copolymerizable acid and/or diol monomers, and (iii) combinations thereof. The polycarbonate component and the polyester component are present in sufficient proportions to form a molding composition capable of being molded into an article that exhibits transparency and structural integrity after the article is exposed to a caustic aqueous environment for at least 70 hours. The invention also relates to articles made from the composition, methods for making the compositions, and methods for using articles.

Abstract: An anti-adhesion agent composition for asphalt contains a specific polycarboxylic acid compound (A); a surfactant (B) that is at least one selected from a betaine amphoteric surfactant, an amino acid amphoteric surfactant, a polyoxyethylene alkylamine surfactant, an alkanolamide surfactant, and an amine oxide surfactant; and a water-soluble polyhydric alcohol (C).

Abstract: An aqueous polymer dispersion that includes a) a polyurethane dispersion having an average particle size of 60 to 350 nm and b) an aqueous silicon dioxide dispersion having a particle diameter of the SiO2 particles of 20 to 400 nm. The dispersion is prepared by mixing the polyurethane dispersion (a) with the silicon dioxide dispersion (b). The aqueous polymer dispersion can be used in adhesive compositions, which can be used to bond substrates together, especially substrates that are structural components of shoes.

Abstract: Polymer articles formed from a modified propylene based polymer and processes of forming the same are described herein. The modified propylene based polymers generally include a propylene based polymer, a nucleator including a hyper nucleator, and a neutralizer composition, wherein the neutralizer composition includes a first compound selected from stearoyl lactylates, lactates, hydrotalcites, hydroxides and combinations thereof and may optionally include a second compound selected from metal stearates, wherein the lactates are selected from modified calcium salts derived from stearic and lactic acids and calcium lactates.

Abstract: The thermoplastic rubber grafted copolymer resin composition comprising (A) about 100 parts by weight of a rubber grafted copolymer prepared by (a1) about 10 to 100 parts by weight of a rubber-modified grafted copolymer and (a2) about 0 to 90 parts by weight of copolymer prepared by vinyl cyanide compound/aromatic vinyl compound or methyl methacrylate or N-phenyl maleimide/vinyl cyanide monomer or aromatic vinyl monomer/methyl methacrylate or N-phenyl maleimide; (B) about 1 to 30 parts by weight of a maleic anhydride copolymer; and (C) about 1 to 20 parts by weight of a clay treated with a compound containing reactive functional groups; wherein said compound containing functional groups has a radical-polymerizable group and an onium ion that can ion-exchange with said clay.

Abstract: A compressed sheet gasketing material is provided with a combination of high elastomer content and high swelling medium content. In one aspect, the swelling medium may include bentonite clay and may be provided a weight percentage that varies from 30 to 60%. In another aspect, a rubber content weight percentage that varies from 20 to 30% provides a relatively high compressibility. The compressed sheet gasketing material may further include one or more various fibers commonly used in high pressure sheet formulations.

Abstract: Described herein is microporous precipitated silica having the following physico-chemical parameters: a CTAB surface area of 50 to 300 square meters/gram, a BET/CTAB ratio of ?1.3, and a relative breadth ? of pore size distribution of ?3.5. The precipitated silica can also have a Sears number of from 10 to 28 and a Sears number/CTAB ratio of ?0.16. Also described herein are vulcanizable and vulcanized elastomer compositions, e.g., tires, containing the microporous precipitated silica.

Abstract: The invention relates to polymers useful as a papermaking additives. The invention also relates to methods for making and using such additives.

Abstract: A carbon black having excellent conductivity-imparting ability, a method for producing the same, and a conductive composition containing the same are disclosed. The carbon black comprises a chain body comprising (1) chain parts of spherical carbon particles and (2) chain parts of rod-shaped carbon particles, the chain part (1) and the chain part (2) being connected, and is produced by supplying a raw material mixture comprising acetylene gas, hydrocarbon and a catalyst for carbon nanotube formation to a high temperature field having a temperature equal to or higher than a thermal decomposition temperature of the hydrocarbon, and heat treating the mixture, or by supplying hydrocarbon containing a catalyst for carbon nanotube formation, during pyrolysis of acetylene gas and/or in the state that acetylene gas has been pyrolyzed, and heat treating the resulting mixture at a temperature equal to or higher than a thermal decomposition temperature of the hydrocarbon.

Abstract: The invention relates to an aqueous polyurethane dispersion suitable for use in personal care products, the dispersed polyurethane comprising the reaction products of: A) a prepolymer according to the formula: wherein R1 represents a bivalent radical of a dihydroxyl functional compound, R2 represents a hydrocarbon radical of an aliphatic or cycloaliphatic polyisocyanate, R3 represents a radical of a low molecular weight diol, optionally substituted with ionic groups, n is from 0 to 5, and m is >1; B) at least one chain extender according to the formula: H2N—R4—NH2 wherein R4 represents an alkylene or alkylene oxide radical not substituted with ionic or potentially ionic groups; and C) at least one chain extender according to the formula: H2N—R5—NH2 wherein R5 represents an alkylene radical substituted with ionic or potentially ionic groups.

Abstract: Metal catalyst residues in resins containing polymerized lactic acid units, such as polylactides, are deactivated by treatment with a polymer or copolymer that contain pendant acid groups and pendant ester groups, with an acid-containing PLA resin, or with a polymer or copolymer having at least one acid groups per 250 atomic mass units and which has pendant lactic acid or poly(lactic acid) groups. The deactivating agent is effective at deactivating the catalyst, and has little effect on the optical clarity of the resin.

Abstract: The present invention relates to a phenolic hydroxy group-containing rubber-modified polyamide resin which has, in the molecule, a phenolic hydroxy group-containing aromatic polyamide segment having a structure represented by the following formula (A) (wherein, m and n are average values and Ar represents a divalent aromatic group) and a butadiene (co)polymer segment selected from the following formula (B-1) or (B-2), —(CH2—CH?CH—CH2)X—??(B-1) —(CH2—CH?CH—CH2)Y—(CH2—CH(CN))Z—??(B-2) (wherein, each of x, y and z is an average value and 0.01?z/(y+z)?0.13, x represents a positive number of 5 to 200, and also y+z is a positive number of 10 to 200), and a resin composition containing said resin, in particular an epoxy resin composition; a cured product of said epoxy resin composition is excellent in flexibility, heat resistance and electrical properties especially at high temperature and high humidity.

Abstract: The present invention provides a polyamide resin composition comprising a resin of polyamide and polyacrylate mixed with a compatibilizer, an inorganic nucleating agent, a glass fiber, an antioxidant, an anti-hydrolysis agent and a lubricant in a predetermined ratio, which shows superior mechanical strength and heat resistance and improved glycol resistance and visibility maintenance, thus being useful in such a field that requires the aforementioned properties, for example in an automobile coolant reservoir tank.

Abstract: Provided is a process for producing a cycloolefin resin composition, comprising a step of hydrogenating a resin composition. The resin composition before hydrogenation, which is used in the above step, includes 0.01 to 20 parts by weight of an unsaturated hydrocarbon compound having a boiling point of 50° C. or higher, for example, a monomer employed in polymerization, per 100 parts by weight of the resin composition.